|
RASAL2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.76728999999876E-05 |
| Normal-vs-Stage3 |
1.62891922173003E-12 |
| Normal-vs-Stage4 |
8.12700018393286E-10 |
| Stage1-vs-Stage2 |
4.265600E-01 |
| Stage1-vs-Stage3 |
5.807400E-01 |
| Stage1-vs-Stage4 |
7.387000E-01 |
| Stage2-vs-Stage3 |
3.115000E-01 |
| Stage2-vs-Stage4 |
4.047200E-01 |
| Stage3-vs-Stage4 |
9.349400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.44339999975341E-07 |
| Normal-vs-Asian |
1.64709999972423E-07 |
| Caucasian-vs-AfricanAmerican |
1.130040E-01 |
| Caucasian-vs-Asian |
9.970400E-01 |
| AfricanAmerican-vs-Asian |
2.192200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62447832963153E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
4.444400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
5.91704463204223E-12 |
| Normal-vs-Age(81-100Yrs) |
1.07780000002666E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.212200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.073600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.887600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.874400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.564600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.593600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.769800E-01 |
| Classical-VS-Follicular |
7.77570000054517E-07 |
| Classical-VS-Other |
1.057410E-01 |
| Classical-VS-Normal |
1.62447832963153E-12 |
| Tall-VS-Follicular |
4.385200E-04 |
| Tall-VS-Other |
4.100000E-02 |
| Tall-VS-Normal |
2.91839885591116E-11 |
| Follicular-VS-Other |
9.965000E-01 |
| Follicular-VS-Normal |
1.85894999999991E-05 |
| Other-VS-Normal |
8.648100E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62592161956354E-12 |
| Normal-vs-N1 |
2.60160004650345E-10 |
| N0-vs-N1 |
5.041600E-02 |
|
|
